Search Results - "Feyssa, Eyob"

S2687 Alcoholic Hepatitis Mimicking Hepatocellular Carcinoma by Shogbesan, Oluwaseun, Lee, Andrew, Altomare, John, Feyssa, Eyob

Get full text

Gallstone Pancreatitis: A Common but Often Overlooked Cause of Abdominal Pain in Post-Liver-Transplant Patients by Feyssa, Eyob, Fatima, Sanna, Lapumnuaypol, Kamolyut, Kanjanahattakij, Napatt

“…Introduction. In general population, gallstone pancreatitis is the most common cause of pancreatitis. However, there are very few literatures that address this…”
Get full text

Operative start times and complications after kidney transplantation by Shaw, Tavis M., Lonze, Bonnie E., Feyssa, Eyob L., Segev, Dorry L., May, Noah, Parsikia, Afshin, Campos, Stalin, Khanmoradi, Kamran, Zaki, Radi F., Ortiz, Jorge A.

“…The worldwide focus on work hour regulations and patient safety has led to the re‐examination of the merits of night‐time surgery, including kidney…”
Get full text

Tc-99m-BrIDA hepatobiliary (HIDA) scan has a low sensitivity for detecting biliary complications after orthotopic liver transplantation in patients with hyperbilirubinemia by Hopkins, L. Olivia, Feyssa, Eyob, Parsikia, Afshin, Khanmoradi, Kamran, Zaki, Radi, Campos, Stalin, Araya, Victor, Tran, Huyen, Ortiz, Jorge

“…Background Tc-99m-BrIDA hepatobiliary scans are noninvasive tests for detecting biliary leaks and obstructions. However, there is low sensitivity and…”
Get full text

Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients by Khanmoradi, Kamran, Knorr, John P, Feyssa, Eyob L, Parsikia, Afshin, Jawa, Pankaj, Dinh, Duy-Bao, Campos, Stalin, Zaki, Radi F, Ortiz, Jorge A

“…The optimal immunosuppression regimen for elderly kidney transplant recipients is poorly defined. We sought to evaluate the short-term efficacy and safety of…”
Get full text

Changes in Characteristics and Patterns of Chronic Hepatitis C Patients Referred for Directacting Antiviral Therapy: 884 by Feyssa, Eyob, Jain, Deepanshu

Get full text

Predictors of Histologic Severity in Chronic Hepatitis B-infected Patients by Araya, Victor, Feyssa, Eyob L, Parsikia, Afshin, Azhar, Ashaur, Thummalakunta, Laxmi, Hashemi, Nikroo, Basi, Puneet, Ortiz, Jorge

“…The role of liver biopsy in chronic Hepatitis B treatment guidelines remains incompletely defined. Our aim was to correlate histologic disease severity with…”
Get full text

An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation by Hashemi, Nikroo, Araya, Victor, Tufail, Kashif, Thummalakunta, Laxmi, Feyssa, Eyob, Azhar, Ashaur, Niazi, Mumtaz, Ortiz, Jorge

“…AIM: To evaluate the efflicacy and tolerability of an extended treatment protocol and to determine the predictors of sustained virological response (SVR) after…”
Get full text

Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant by Ortiz, Jorge, Feyssa, Eyob L, Parsikia, Afshin, Azhar, Ashaur, Hashemi, Nikroo, Campos, Stalin, Khanmoradi, Kamran, Zaki, Radi, Balasubramanian, Manjula, Araya, Victor

“…The rate of hepatitis C virus recurrence after donation after cardiac death liver transplant is not clearly defined. This is a retrospective review of 39…”
Get more information

Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report by Niazi, Mumtaz A, Azhar, Ashaur, Tufail, Kashif, Feyssa, Eyob L, Penny, Stephen F, McGregory, Marlene, Araya, Victor, Ortiz, Jorge A

“…The recommended therapy for chronic hepatitis C (CHC) infection is the combination of a Pegylated interferon and Ribavirin. Almost all such patients on…”
Get full text

Overcoming a treatment barrier in treating hepatitis C in dialysis patients by Lapumnuaypol, Kamolyut, Feyssa, Eyob

Get full text

Racial/Ethnic Disparity in Kidney Transplantation Outcomes: Influence of Donor andRecipient Characteristics by Feyssa, Eyob, MD, MPH, Charlotte, Jones-Burton, MD, Ellison, Gary, PhD, Philosophe, Benjamin, MD, PhD, Howell, Charles, MD

“…Objective The purpose of this study was to evaluate the basis for the racial/ethnic disparity in kidney allograft survival. Methods We conducted a…”
Get full text

Su1699 LABORATORY SCORES (APRI AND FIB-4) AND TRANSIENT ELASTOGRAPHY TO RULE OUT LIVER FIBROSIS IN HEPATITIS C AND ESRD PATIENTS BEING EVALUATED FOR RENAL TRANSPLANTATION by DiMaria, Christina N., Feyssa, Eyob, Murone, Julie, Goyal, Abhinav

Get full text

Treatment of Hepatitis C in the Post Liver Transplant Patient: 914 by Kleinman, Bryan M., DePalma, Richard, Feyssa, Eyob

Get full text

Role of Neo-Adjuvant TIPS in Child Pugh Class A and B Cirrhotic Patients Undergoing Elective Intra-Abdominal Surgery: 2865 by Bandres, Maria, Jain, Deepanshu, Mahmood, Ejaz, Lapumnuaypol, Kamolyut, Feyssa, Eyob

“…Introduction: Portal hypertension is routinely diagnosed and managed among cirrhotic patients. TIPS (trans-jugular intrahepatic portosystemic shunt) is a…”
Get full text

Mo1407 - Direct Acting Antiviral Agents for Hepatitis C Treatment Among Post Kidney Transplant Patients by Jain, Deepanshu, Shah, Jay, Kalman, Richard, Feyssa, Eyob

Get full text

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1 by Boyer, Thomas D, Sanyal, Arun J, Wong, Florence, Frederick, R. Todd, Lake, John R, O’Leary, Jacqueline G, Ganger, Daniel, Jamil, Khurram, Pappas, Stephen Chris

“…Background & Aims Hepatorenal syndrome type 1 (HRS-1) in patients with cirrhosis and ascites is a functional, potentially reversible, form of acute kidney…”
Get full text

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension by Garcia‐Tsao, Guadalupe, Fuchs, Michael, Shiffman, Mitchell, Borg, Brian B., Pyrsopoulos, Nikolaos, Shetty, Kirti, Gallegos‐Orozco, Juan F., Reddy, K. Rajender, Feyssa, Eyob, Chan, Jean L., Yamashita, Mason, Robinson, James M., Spada, Alfred P., Hagerty, David T., Bosch, Jaime

“…Caspases play a central role in apoptosis, inflammation, and fibrosis. They produce hemodynamically active, proinflammatory microparticles that cause…”
Get full text

Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery by Jain, Deepanshu, Mahmood, Ejaz, V-Bandres, Maria, Feyssa, Eyob

“…Despite improvements in the surgical techniques, anesthesia and intensive care, abdominal surgery in patients with cirrhosis remains a challenge. Transjugular…”
Get full text

Tu1529 - Multidisciplinary Approach to the Treatment of Chronic Hepatitis C: The Match Initiative by Sandhu, Naemat, Mulki, Ramzi, Tosounian, Shannon, Wheeler, David, Feyssa, Eyob, Baumann, Alexandra

Get full text